Eur Rev Med Pharmacol Sci 2019; 23 (5): 2182-2187

DOI: 10.26355/eurrev_201903_17264

Effect of NT-3 on infection-induced memory impairment of neonatal rats

D.-B. Liu, J.-S. Yang, Q.-B. Lu, Z.-F. Zhu, Q. Fang

Department of Neurology, The Affiliated Jiangyin Hospital of Southeast University of Medical College, Jiangyin, Jiangsu, China. z9m4x7@163.com


OBJECTIVE: To explore the effect of neurotrophin-3 (NT-3) messenger ribonucleic acid (mRNA) in the hippocampus on infection-induced memory impairment of neonatal rats.

MATERIALS AND METHODS: 80 female Sprague-Dawley (SD) rats in the neonatal stage were selected to establish memory impairment model by bacterial meningitis infection. Rats were randomly divided into experimental group (n=40) and control group (n=40). Rats in experimental group were injected with β-amyloid precursor protein 319-335 peptide APP17p into brain tissue to up-regulate the expression of NT-3, and the rats in control group didn’t receive treatment. Behavioral changes of rats were observed in Morris water maze and passive avoidance experiment. Apoptosis of nerve cells was detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) method and Fluoro-Jade B method. NT-3 mRNA expression level was measured via reverse transcription polymerase chain reaction (RT-PCR).

RESULTS: NT-3 expression level in experimental group was higher than that in control group (p<0.05). Apoptosis rate of nerve cells in experimental group was lower than that in control group, but the learning and memory ability of rats in experimental group was better than that in control group (p<0.05).

CONCLUSIONS: Reduced NT-3 expression level may be correlated with the occurrence of meningitis because NT-3 can suppress nerve cell apoptosis and ameliorate learning and memory impairment to a certain extent to exert neuroprotective effects.

Free PDF Download

To cite this article

D.-B. Liu, J.-S. Yang, Q.-B. Lu, Z.-F. Zhu, Q. Fang
Effect of NT-3 on infection-induced memory impairment of neonatal rats

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 5
Pages: 2182-2187
DOI: 10.26355/eurrev_201903_17264